Our Company

Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem manufactures and sells the t:slim X2™ Insulin Pump, the only pump capable of remote feature updates using a personal computer, and the t:flex® Insulin Pump, the first pump designed for people with greater insulin requirements. Tandem is based in San Diego, California.

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Tandem Diabetes Care's financial performance into perspective.

Stock Quote
NASDAQ: TNDM
Price:
$2.92
Change:
+ 0.11
Day High:
3.00
Day Low:
2.61
Volume:
896,312
3:59 PM ET on Jan 17, 2018

View all »   RSSRecent Releases

Jan 9, 2018
Tandem Diabetes Care Announces Preliminary 2017 Results and Provides 2018 Guidance

Jan 8, 2018
Tandem Diabetes Care Reports Successful Completion of First Pilot Study Using t:slim X2 Insulin Pump with TypeZero Hybrid Closed Loop Technology and Dexcom G6 Integration; Confirms IDCL Multi-site Study Timeline